Guidance, tools & data

Equity & zero-dose

Research principles for costing studies reaching zero-dose children

Research principles for studies that aim to estimate the cost of reaching zero-dose children. This document is the result of a consultative process that involved the Gavi Secretariat, WHO, UNICEF, the Bill & Melinda Gates Foundation, ThinkWell, CDC, JSI, VillageReach, PATH, Boston University, Swiss Tropical and Public Health Institute, Levin & Morgan LLC, and the University of Montreal [2024].

Distributional cost-effectiveness analysis handbook

Methods for quantifying the equity impacts of health programs in high, middle, and low-income countries. The methods can be tailored to analyze different equity concerns in different decision-making contexts [University of York, 2020].

Standardized approach for measuring coverage equity

Publication which gives a standardized approach for measuring multivariate equity in vaccine coverage, economic impact, and health outcomes [VERSE project, 2022].

Vaccine coverage and equity toolkit

This toolkit enables users to compare the level of vaccine coverage against the level of equity in a country and quantify the influence of key sociodemographic factors to inequity [VERSE project, 2022].

Estimating the cost of reaching zero dose children: a guide for the Zero-Dose Learning Agenda (ZDLA)

This Guide presents a standardized approach for evaluating the incremental costs of ZDLA interventions. It was developed for use by the ZDLA country teams who had limited prior experience with cost analysis. It is not meant to be fully exhaustive of costing methodologies but to complement other standardized methods available.

Provide your feedback

If you have any suggestions of further guidance documents or tools for this page, please send them to immunization_economics@kemri-wellcome.org.